or Try an Advanced Search...

    Technical Analysis for BOLT - Bolt Biotherapeutics, Inc.

    Grade Last Price % Change Price Change
    F 0.57 0.46% 0.00
    BOLT closed up 1.59 percent on Wednesday, November 20, 2024, on 42 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BOLT trend table...
    Date Alert Name Type % Chg
    Lower Bollinger Band Walk Weakness 0.46%
    Inside Day Range Contraction 0.46%
    Lower Bollinger Band Touch Weakness 0.46%
    Oversold Stochastic Weakness 0.46%
    Bullish Engulfing Bullish 2.05%
    Stochastic Buy Signal Bullish 2.05%
    Doji - Bullish? Reversal 2.05%
    Lower Bollinger Band Walk Weakness 2.05%
    New 52 Week Low Weakness 2.05%
    Outside Day Range Expansion 2.05%
    Older End-of-Day Signals for BOLT ...

       Recent Intraday Alerts

    Alert Time
    Lower Bollinger Band Support about 2 hours ago
    60 Minute Opening Range Breakdown about 3 hours ago
    Down 3% about 3 hours ago
    Fell Below Previous Day's Low about 3 hours ago
    Down 2 % about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    BOLT Chart by TradingView
    Basic chart:

    Profile

    Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, engages in the discovery, development, and commercialization of pharmaceutical products. The company develops BDC-1001, a human epidermal growth factor receptor 2 (HER2) for the treatment of patients with HER2-expressing solid tumors, including HER2-low tumors. Its preclinical stage product candidates include carcinoembryonic antigen program for colorectal, non-small cell lung, pancreatic, and breast cancers; programmed cell death-ligand 1 program for tumors that are nonresponsive to immune checkpoint blockade; and myeloid modulators. Bolt Biotherapeutics, Inc. was founded in 2015 and is based Redwood city, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Clinical Medicine Tumor Pharmaceutical Products Cancer Immunotherapy Breast Cancer Immune Checkpoint Her2/Neu

    Is BOLT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 15 Bolt Biotherapeutics Third Quarter 2024 Earnings: Misses Expectations
    Nov 13 Bolt Biotherapeutics reports Q3 results
    Nov 13 Bolt Biotherapeutics GAAP EPS of -$0.40, revenue of $1.14M
    Nov 12 Bolt Biotherapeutics, Inc. (BOLT) Reports Q3 Loss, Tops Revenue Estimates
    Nov 12 Bolt Biotherapeutics Inc.: Q3 Earnings Snapshot
    Nov 12 Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
    Nov 9 Here's Why We're Watching Bolt Biotherapeutics' (NASDAQ:BOLT) Cash Burn Situation
    Nov 7 Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
    Sep 4 Bolt Biotherapeutics Announces Changes to its Board of Directors
    Aug 28 Bolt Biotherapeutics to Participate in Upcoming September Conferences
    See more BOLT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.56
    52 Week Low 0.54
    Average Volume 139,072
    200-Day Moving Average 0.86
    50-Day Moving Average 0.63
    20-Day Moving Average 0.63
    10-Day Moving Average 0.61
    Average True Range 0.04
    RSI (14) 33.77
    ADX 20.39
    +DI 9.59
    -DI 23.14
    Chandelier Exit (Long, 3 ATRs) 0.61
    Chandelier Exit (Short, 3 ATRs) 0.65
    Upper Bollinger Bands 0.71
    Lower Bollinger Band 0.56
    Percent B (%b) 0.09
    BandWidth 24.07
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0103
    Fundamentals Value
    Market Cap 21.64 Million
    Num Shares 38 Million
    EPS -1.89
    Price-to-Earnings (P/E) Ratio -0.30
    Price-to-Sales 5.68
    Price-to-Book 0.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.62
    Resistance 3 (R3) 0.62 0.61 0.61
    Resistance 2 (R2) 0.61 0.59 0.61 0.61
    Resistance 1 (R1) 0.59 0.58 0.60 0.59 0.61
    Pivot Point 0.57 0.57 0.58 0.57 0.57
    Support 1 (S1) 0.55 0.56 0.56 0.55 0.53
    Support 2 (S2) 0.54 0.55 0.54 0.53
    Support 3 (S3) 0.52 0.54 0.53
    Support 4 (S4) 0.52